There has been a significant fall in the number of cases of HPV, the virus that causes cervical cancer, following the introduction of a vaccine for young women | Public Health England | Journal of Infectious Diseases
HPV infections in women aged 16 to 21 fell by 86% between 2010 and 2016, a new study shows. Experts say these results suggest that the vaccine, introduced just 10 years ago, could eventually lead to a virtual eradication of the disease, which kills around 850 women a year.
Public Health England’s head of immunisation, Dr Mary Ramsay, said: “These results are very promising and mean that in years to come we can expect to see significant decreases in cervical cancer. “The study also reminds us how important it is to keep vaccination rates high to reduce the spread of this preventable infection. I encourage all parents of girls aged 12 to 13 to make sure they take up the offer for this potentially life-saving vaccine.”
Journal reference: Mesher, D. et al. | The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010–2016 | The Journal of Infectious Diseases, https://doi.org/10.1093/infdis/jiy249
Public Health Matters blog: Ten years on since the start of the HPV vaccine programme – what impact is it having?